Sinclair and Harvard Medical School Join Forces to Shape the Future of Medical Aesthetics

The Magic Wand Initiative (MWI) Asia-Pacific Graduation Ceremony was recently held at Harvard Medical School’s Massachusetts General Hospital (MGH). The program was introduced to Asia for the first time in 2024, thanks to a strategic collaboration between Sinclair, a global leader in medical aesthetics innovation, and Harvard Medical School. Over the course of a year, Harvard Medical School experts led this comprehensive innovation training program, which engaged physicians from across Asia-Pacific in transforming clinical experience into standardized tools. The program aims to cultivate a new generation of medical aesthetics professionals—equipped with both clinical expertise and innovative thinking. As of 2025, the program has already yielded ten incubated medical innovation projects, each of which has the potential to revolutionize the future of medical aesthetics.

MWI: A Flagship Program at Harvard Medical School’s Massachusetts General Hospital

The Magic Wand Initiative (MWI) was established at the Wellman Center for Photomedicine at MGH, one of the world’s leading institutions for medical innovation and immersive education. Since its launch in 2013, MWI has earned widespread recognition within the U.S. medical community. Founded by Professor Rox Anderson, known as the Father of Modern Laser Medicine, and Dr. Lilit Garibyan, a physician-scientist at Harvard Medical School and the Wellman Center, the initiative continues to drive medical research and development on a global scale.

MWI has a rigorous selection process, bringing together elite physicians from top medical institutions, including Harvard Medical School, The University of Chicago Pritzker School of Medicine, and Icahn School of Medicine at Mount Sinai.The program focuses on cutting-edge medical education, dedicated to fostering innovation in clinical training and continuously driving advancements in the medical aesthetics industry. To date, it has nurtured over 100 global medical opinion leaders. Through a 10-month systematic curriculum, MWI empowers clinical physicians to transition from practitioners to innovators, equipping them with the skills to tackle unresolved medical challenges while identifying unmet patient needs. By leveraging a synergistic ecosystem of industry, academia, and research, MWI connects the world’s top hospitals, enterprises, and universities, offering physicians comprehensive support and guidance. The program has already yielded numerous breakthrough innovations, enhancing treatment options for medical aesthetics patients worldwide and accelerating medical advancements. Following its success in the U.S., the program has now expanded into Europe and Asia.

With its core philosophy of “Training, Inspiring, and Connecting the Next Generation of Innovators”, MWI leverages medical education as a foundation to build a world-class academic exchange platform. It addresses current industry challenges and promotes the simultaneous advancement of medical education and technological innovation, driving a significant leap forward in the Asia-Pacific medical aesthetics industry. The transformation of the medical aesthetics sector begins with empowering doctors at the source, emphasizing the importance of innovation-driven medical education. The establishment of MWI in the Asia-Pacific region is poised to accelerate the industry's rapid development.

Excelling in Education, Embracing Innovation, Leading the Future of Medical Aesthetics

The MWI Graduation Ceremony brought together a distinguished lineup of medical experts, including: Professor Rox Anderson (Director of the Wellman Center), Dr. Lilit Garibyan (Co-Founder of MWI), Dr. Kachiu Lee, Dr. Wang Ying, and 18 of the most outstanding clinical physicians from across the Asia-Pacific region. Key topics presented included “Reducing Injection Pain in Scar Hypertrophy Treatment” and other groundbreaking insights.

During his speech, Professor Rox Anderson emphasized that “Medical education and innovation are invaluable; they are essential steps we must take. We must constantly push boundaries, embrace challenges, and never fear failure. We are confident in tackling the unknown.” Following this, Dr. Lilit Garibyan highlighted MWI’s proven success in the U.S. and the tremendous contributions of its participants: “MWI has a long history of excellence in the U.S., made possible by the dedication of our participants. Their innovative spirit, passion, and courage in taking on challenges have driven remarkable medical breakthroughs. Thanks to our partnership with Sinclair, we are now in Asia, and I believe we will create even better solutions tailored to the needs of Asian skin.”

Speaking on the role of innovation, Audrey, Global Business Development Director at Sinclair, remarked that “True innovation is not about being different for the sake of it—it’s about solving real problems and creating meaningful change. MWI and Sinclair share the same belief: bringing truly effective products to the market. A great product must address unmet needs, enhance treatment outcomes, and genuinely benefit patients. This is not just our vision—it is our mission.”

Rooted in Innovation, Committed to Excellence, Delivering Lasting Value to Consumers

As a global medical aesthetics company integrating R&D, manufacturing, sales, and services, Sinclair has nearly 50 years of scientific research heritage and operates six innovation centers worldwide. Medical innovation and education remain at the heart of the company’s long-term investments. The collaboration between Sinclair and Harvard Medical School’s Massachusetts General Hospital has successfully introduced MWI to Asia, elevating the medical aesthetics field to new academic heights.

As Chinese medical aesthetics consumers become more sophisticated, their focus has shifted from short-term, standardized treatments to safe, personalized, and natural results with lasting value. Meeting these evolving needs requires a strong foundation in medical expertise, as physicians serve as the final bridge between technology and patient care. Looking ahead, Sinclair and Harvard Medical School’s Massachusetts General Hospital will deepen their collaboration through MWI, advancing medical value and technological innovation. By anchoring leadership in medical education, Sinclair will continue to invest in academic innovation projects, linking Asia-Pacific scholars with Harvard’s world-class research platform. This initiative will empower top-tier injectors and laser physicians across Asia-Pacific, addressing clinical pain points with superior solutions. Ultimately, it will help transition China from a major player in medical aesthetics to a true global leader in the field.